21 May 2013
Keywords: Endo Pharma, Penwest Pharma, M&A, Oxymorphone, Financial guidance
Article | 10 August 2010
In a move designed to advance the company's leadership and growth in pain management, Endo Pharmaceuticals plans to acquire all ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 August 2010
11 August 2010
20 May 2013
© 2013 thepharmaletter.com